Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
General Surgery | 1 | 2022 | 1720 | 0.360 |
Why?
|
Inpatients | 3 | 2024 | 2563 | 0.270 |
Why?
|
Internship and Residency | 1 | 2022 | 5947 | 0.200 |
Why?
|
Liver Transplantation | 2 | 2023 | 2416 | 0.180 |
Why?
|
End Stage Liver Disease | 1 | 2023 | 369 | 0.150 |
Why?
|
Patient Admission | 1 | 2024 | 1364 | 0.140 |
Why?
|
Kidney Transplantation | 2 | 2023 | 4268 | 0.130 |
Why?
|
Dacryocystitis | 1 | 2016 | 68 | 0.130 |
Why?
|
Transplantation Tolerance | 1 | 2019 | 639 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1214 | 0.120 |
Why?
|
Immune Tolerance | 2 | 2020 | 2322 | 0.110 |
Why?
|
Graft Survival | 2 | 2023 | 3896 | 0.100 |
Why?
|
Lymphoproliferative Disorders | 1 | 2016 | 527 | 0.100 |
Why?
|
Hemorrhage | 1 | 2024 | 3464 | 0.100 |
Why?
|
Ohio | 2 | 2024 | 321 | 0.100 |
Why?
|
Morphogenesis | 1 | 2015 | 746 | 0.100 |
Why?
|
Muscle, Smooth | 1 | 2015 | 930 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2030 | 0.090 |
Why?
|
Epithelium | 1 | 2015 | 1606 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2330 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2420 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 616 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3114 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2020 | 2745 | 0.080 |
Why?
|
Communication | 1 | 2022 | 3904 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1559 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4357 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2024 | 81659 | 0.070 |
Why?
|
Databases, Factual | 1 | 2022 | 8068 | 0.070 |
Why?
|
Clinical Competence | 1 | 2022 | 4859 | 0.070 |
Why?
|
Hypertension | 1 | 2021 | 8615 | 0.040 |
Why?
|
Brain Death | 1 | 2023 | 360 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2022 | 588 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 2020 | 624 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 2019 | 915 | 0.040 |
Why?
|
Living Donors | 1 | 2023 | 647 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11657 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2020 | 828 | 0.040 |
Why?
|
Hospitalists | 1 | 2021 | 294 | 0.030 |
Why?
|
Lung | 1 | 2015 | 10076 | 0.030 |
Why?
|
Incidental Findings | 1 | 2021 | 698 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 1995 | 0.030 |
Why?
|
Cell Separation | 1 | 2020 | 1717 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2006 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2015 | 789 | 0.030 |
Why?
|
Humans | 9 | 2024 | 767040 | 0.030 |
Why?
|
Tissue Donors | 1 | 2023 | 2387 | 0.030 |
Why?
|
Cell Communication | 1 | 2020 | 1660 | 0.030 |
Why?
|
Mice | 4 | 2022 | 81912 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1626 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2022 | 5499 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 22361 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2472 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1883 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4838 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 6226 | 0.020 |
Why?
|
Survival Analysis | 1 | 2023 | 10092 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5891 | 0.020 |
Why?
|
Critical Care | 1 | 2022 | 2714 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4572 | 0.020 |
Why?
|
Actins | 1 | 2015 | 2059 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5022 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15424 | 0.020 |
Why?
|
Animals | 4 | 2022 | 168965 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59548 | 0.020 |
Why?
|
Graft Rejection | 1 | 2020 | 4498 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74886 | 0.020 |
Why?
|
Male | 5 | 2024 | 364203 | 0.020 |
Why?
|
Age Factors | 1 | 2023 | 18401 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20169 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2020 | 3305 | 0.020 |
Why?
|
Aged | 3 | 2024 | 171319 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2023 | 15925 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9410 | 0.010 |
Why?
|
Kidney | 1 | 2020 | 7063 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 223233 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15851 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9551 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24299 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 26396 | 0.010 |
Why?
|
Female | 4 | 2024 | 396660 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8736 | 0.010 |
Why?
|
Child | 2 | 2023 | 80771 | 0.010 |
Why?
|
Time Factors | 1 | 2023 | 40154 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36485 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12793 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18330 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42606 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18989 | 0.010 |
Why?
|
Signal Transduction | 1 | 2022 | 23621 | 0.010 |
Why?
|
Adult | 2 | 2023 | 223317 | 0.010 |
Why?
|
Young Adult | 1 | 2023 | 59980 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65295 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 89046 | 0.000 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_